Fischer Medical Ventures Limited (BOM: 524743)
India
· Delayed Price · Currency is INR 666.95
-5.90 (-0.88%)
At close: Oct 10, 2024
Fischer Medical Ventures Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Operating Revenue | 311.02 | 209.81 | 1.8 | - | 1.65 | 1.84 | Upgrade
|
| Other Revenue | 12.43 | - | - | - | - | - | Upgrade
|
| Revenue | 323.45 | 209.81 | 1.8 | - | 1.65 | 1.84 | Upgrade
|
| Revenue Growth (YoY) | 17919.44% | 11588.75% | - | - | -10.28% | -4.47% | Upgrade
|
| Cost of Revenue | 250.69 | 165.77 | - | - | 0.8 | 0.89 | Upgrade
|
| Gross Profit | 72.76 | 44.05 | 1.8 | - | 0.85 | 0.95 | Upgrade
|
| Selling, General & Admin | 7.68 | 5.11 | 0.63 | 0.9 | - | 0.13 | Upgrade
|
| Other Operating Expenses | 34.86 | 20.35 | 1.01 | 0.98 | 1.03 | 1.05 | Upgrade
|
| Operating Expenses | 47.13 | 27.27 | 1.64 | 1.89 | 1.03 | 1.18 | Upgrade
|
| Operating Income | 25.63 | 16.78 | 0.15 | -1.89 | -0.18 | -0.23 | Upgrade
|
| Interest Expense | -1.77 | -0.68 | -0.17 | -0.09 | -0.18 | -0.18 | Upgrade
|
| Interest & Investment Income | - | 4.95 | - | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.87 | 0.06 | -0 | - | - | - | Upgrade
|
| Pretax Income | 22.99 | 21.11 | -0.01 | -1.97 | -0.36 | -0.41 | Upgrade
|
| Income Tax Expense | 3.61 | 2.73 | 0.35 | 0.35 | -1.76 | - | Upgrade
|
| Net Income | 19.38 | 18.38 | -0.37 | -2.33 | 1.41 | -0.41 | Upgrade
|
| Net Income to Common | 19.38 | 18.38 | -0.37 | -2.33 | 1.41 | -0.41 | Upgrade
|
| Shares Outstanding (Basic) | - | 11 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | - | 17 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | - | 9752.91% | - | - | - | - | Upgrade
|
| EPS (Basic) | - | 1.65 | -2.12 | -13.52 | 8.17 | -2.39 | Upgrade
|
| EPS (Diluted) | - | 1.08 | -2.12 | -13.52 | 8.17 | -2.39 | Upgrade
|
| Free Cash Flow | - | -78.88 | -1.46 | -1.77 | -0.57 | 0.12 | Upgrade
|
| Free Cash Flow Per Share | - | -4.65 | -8.48 | -10.28 | -3.33 | 0.69 | Upgrade
|
| Gross Margin | 22.50% | 20.99% | 100.00% | - | 51.76% | 51.60% | Upgrade
|
| Operating Margin | 7.92% | 8.00% | 8.52% | - | -10.67% | -12.52% | Upgrade
|
| Profit Margin | 5.99% | 8.76% | -20.33% | - | 85.21% | -22.31% | Upgrade
|
| Free Cash Flow Margin | - | -37.60% | -81.28% | - | -34.73% | 6.50% | Upgrade
|
| EBITDA | - | 17.68 | - | - | - | - | Upgrade
|
| EBITDA Margin | - | 8.43% | - | - | - | - | Upgrade
|
| D&A For EBITDA | - | 0.91 | - | - | - | - | Upgrade
|
| EBIT | 25.63 | 16.78 | 0.15 | -1.89 | -0.18 | -0.23 | Upgrade
|
| EBIT Margin | 7.92% | 8.00% | 8.52% | - | -10.67% | -12.52% | Upgrade
|
| Effective Tax Rate | 15.69% | 12.95% | - | - | - | - | Upgrade
|
| Revenue as Reported | 323.45 | 214.83 | 1.8 | - | 1.65 | 1.84 | Upgrade
|
| Advertising Expenses | - | 0.4 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.